Dorsey Wright & Associates’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-34,082
Closed -$6.82M 327
2020
Q2
$6.82M Sell
34,082
-2,889
-8% -$598K 1.39% 8
2020
Q1
$7.24M Sell
36,971
-6,460
-15% -$1.39M 2.75% 2
2019
Q4
$8.98M Sell
43,431
-1,807
-4% -$334K 2.97% 4
2019
Q3
$6.91M Sell
45,238
-582
-1% -$95.4K 1.74% 8
2019
Q2
$5.91M Sell
45,820
-2,771
-6% -$329K 1.43% 13
2019
Q1
$5.72M Buy
48,591
+289
+0.6% +$29.1K 1.38% 17
2018
Q4
$4.43M Sell
48,302
-17,442
-27% -$1.77M 1.32% 16
2018
Q3
$7.39M Sell
65,744
-32,800
-33% -$3.47M 1.35% 18
2018
Q2
$9.31M Buy
98,544
+8,186
+9% +$794K 1.37% 27
2018
Q1
$8.73M Buy
90,358
+24,171
+37% +$2.61M 1.35% 33
2017
Q4
$6.21M Buy
66,187
+17,830
+37% +$1.69M 1.12% 38
2017
Q3
$4.94M Buy
48,357
+14,788
+44% +$1.29M 1.14% 29
2017
Q2
$2.57M Buy
+33,569
New +$2.82M 0.79% 55

Other funds holding LKFT

Dorsey Wright & Associates's LKFT Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 34,082 shares — an estimated $6.82M sold.

Dorsey Wright & Associates first reported a position in LKFT in Q2 2017 and held it in 13 quarters. The position peaked at $9.31M in Q2 2018. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 34,082 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $6.82M.
  • Dorsey Wright & Associates first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 13 quarters.
  • Dorsey Wright & Associates's Lakefront Biotherapeutics American Depositary Shares position peaked at $9.31M in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.